EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Susceptibility of perivenous macrophages to PRRSV-1 subtype 1 LV and PRRSV-1 subtype 3 Lena using a new vein explant model

Shaojie Han, Dayoung Oh, Jiexiong Xie, Hans J Nauwynck

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1223530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Shaojie Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Mer…. Hauptthemen laut MEDLINE: Porcine respiratory and reproductive syndrome virus, Porcine Reproductive and Respiratory Syndrome, African Swine Fever. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vessel pathology such as increased permeability and blue discoloration is frequently observed with highly pathogenic PRRSV strains. However, data concerning the viral replication in the environment of blood vessels are absent. In the present study, ex vivo models with swine ear and hind leg vein explants were established to study the interaction of PRRSV-1 subtype 1 reference strain LV and highly pathogenic subtype 3 strain Lena with perivenous macrophages. The replication characteristics of these two strains were compared in vein explants by immunofluorescence analysis. The explants maintained a good viability during 48 hours of in vitro culture. We found that CD163-positive macrophages were mainly present around the veins and their number gradually decreased with increasing distance from the veins and longer incubation time. More CD163 + Sn - cells than CD163 + Sn + cells (6.6 times more) were observed in the vein explants. The Lena strain demonstrated a higher replication level than the LV strain, with approximately 1.4-fold more infected cells in the surrounding areas of the ear vein and 1.1-fold more infected cells in the leg vein explants at 48 hours post inoculation. In both LV and Lena inoculated vein explants, most infected cells were identified as CD163 + Sn + (> 94%). In this study, an ex vivo vein model was successfully established, and our findings will contribute to a better understanding of the vein pathology during viral infections (e.g., PRRS, classical and African swine fever).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porcine respiratory and reproductive syndrome virusPorcine Reproductive and Respiratory SyndromeAfrican Swine FeverSwineAnimalsMacrophagesVirus Replication

Stichwörter der Autor:innen

immunofluorescence stainingperivenous macrophagesporcine reproductive and respiratory syndrome virusvascular pathologyvessel explant

Autor:innen und Institutionen

  • Laboratory of Virology, Department of Translational Physiology, Infectiology and Public Health, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.

Förderung

  • China Scholarship Council

Zitieren

APA

Han, S., Oh, D., Xie, J., & Nauwynck, H. J. (2023). Susceptibility of perivenous macrophages to PRRSV-1 subtype 1 LV and PRRSV-1 subtype 3 Lena using a new vein explant model. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1223530

Vancouver

Han S, Oh D, Xie J, Nauwynck HJ. Susceptibility of perivenous macrophages to PRRSV-1 subtype 1 LV and PRRSV-1 subtype 3 Lena using a new vein explant model. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1223530

BibTeX
@article{Han2023,
  author = {Han, Shaojie and Oh, Dayoung and Xie, Jiexiong and Nauwynck, Hans J},
  title = {Susceptibility of perivenous macrophages to PRRSV-1 subtype 1 LV and PRRSV-1 subtype 3 Lena using a new vein explant model},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1223530}
}
Kostenlos starten →